Dura Pharmaceuticals, Inc. v. Broudo, 544 U.S. 336 (2005), is a securities fraud decision by the Supreme Court of the United States, holding that an inflated...
3 KB (291 words) - 02:08, 13 September 2023
misrepresentation or omission caused the plaintiff's economic loss. See Dura Pharmaceuticals, Inc. v. Broudo, 544 U.S. 336 (2005). Each of the elements has been heavily...
21 KB (2,979 words) - 18:12, 27 October 2024
Rousey v. Jacoway 544 U.S. 320 2005 Dura Pharmaceuticals, Inc. v. Broudo 544 U.S. 336 2005 Pasquantino v. United States 544 U.S. 349 2005 Small v. United...
3 KB (71 words) - 02:36, 13 September 2023
Dura Pharmaceuticals, Inc. v. Broudo 544 U.S. 336 (2005) standard for pleading loss causation in a securities fraud claim Small v. United States 544 U...
71 KB (68 words) - 01:14, 23 July 2024
(2005) O'Connor, Souter, Ginsburg 208 Brown v. Payton 544 U.S. 133 (2005) 109 Dura Pharmaceuticals v. Broudo 544 U.S. 336 (2005) Securities regulation Unanimous...
17 KB (71 words) - 14:59, 26 May 2024
changed. In Howell v. Mississippi, 543 U.S. 440 (2005), the Court dismissed the writ of certiorari as improvidently granted. In Medellín v. Dretke, 544 U...
68 KB (170 words) - 00:47, 19 February 2024